3.055
0.065 (2.17%)
0.065 (2.17%)
Upgrade to Real-Time
Regular Market
| Volume | 407,469 |
|
|||||
| News | - | ||||||
| Day High | 3.09 | Low High |
|||||
| Day Low | 2.90 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cardiff Oncology Inc | CRDF | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.065 | 2.17% | 3.055 | 13:34:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.05 | 2.90 | 3.09 | 2.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,753 | 407,469 | $ 3.01 | $ 1,227,132 | - | 1.13 - 8.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:36:59 | 50 | $ 3.0591 | USD |
Period:
Draw Mode:
Cardiff Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 132.39M | 43.33M | 42.66M | $ 359.00k | $ - | -0.72 | -3.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 124.32k | 3.80% |
Cardiff Oncology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRDF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.16 | 3.10 | 2.16 | 2.77 | 738,169 | 0.895 | 41.44% |
| 1 Month | 2.80 | 3.10 | 1.8901 | 2.47 | 523,477 | 0.255 | 9.11% |
| 3 Months | 1.29 | 3.41 | 1.15 | 2.23 | 1,004,546 | 1.77 | 136.82% |
| 6 Months | 3.30 | 3.41 | 1.13 | 2.17 | 831,591 | -0.245 | -7.42% |
| 1 Year | 5.99 | 8.58 | 1.13 | 4.28 | 926,038 | -2.94 | -49.0% |
| 3 Years | 1.64 | 25.50 | 0.701 | 6.89 | 1,063,097 | 1.42 | 86.28% |
| 5 Years | 0.773 | 25.50 | 0.206 | 4.64 | 1,055,109 | 2.28 | 295.21% |
Cardiff Oncology Description
| Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. |